Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Variability in hemoglobin A1c predicts all-cause mortality in patients with type 2 diabetes.

Ma WY, Li HY, Pei D, Hsia TL, Lu KC, Tsai LY, Wei JN, Su CC.

J Diabetes Complications. 2012 Jul-Aug;26(4):296-300. doi: 10.1016/j.jdiacomp.2012.03.028. Epub 2012 May 23.

PMID:
22626873
2.

Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5·5-year prospective analysis.

Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC.

Eur J Clin Invest. 2012 Mar;42(3):245-53. doi: 10.1111/j.1365-2362.2011.02574.x. Epub 2011 Aug 5.

PMID:
21815887
3.

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.

Cavalot F, Pagliarino A, Valle M, Di Martino L, Bonomo K, Massucco P, Anfossi G, Trovati M.

Diabetes Care. 2011 Oct;34(10):2237-43. doi: 10.2337/dc10-2414.

4.

Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus.

Ueda H, Mitsusada N, Harimoto K, Miyawaki M, Yasuga Y, Hiraoka H.

Cardiology. 2010;116(1):51-7. doi: 10.1159/000314331. Epub 2010 May 10.

PMID:
20453503
5.

Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.

Lin CC, Chen CC, Chen FN, Li CI, Liu CS, Lin WY, Yang SY, Lee CC, Li TC.

Am J Med. 2013 Nov;126(11):1017.e1-10. doi: 10.1016/j.amjmed.2013.04.015. Epub 2013 Aug 29.

PMID:
23993260
6.

Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.

Selim G, Stojceva-Taneva O, Spasovski G, Georgievska-Ismail L, Zafirovska-Ivanovska B, Gelev S, Dzekova P, Trajcevska L, Trojacanec-Piponska S, Sikole A.

Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.

PMID:
21757955
7.

Lipid but not glycaemic parameters predict total mortality from type 2 diabetes mellitus in Canterbury, New Zealand.

Florkowski CM, Scott RS, Moir CL, Graham PJ.

Diabet Med. 1998 May;15(5):386-92.

PMID:
9609360
8.

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.

Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH; Finnish Diabetic Nephropathy Study Group.

Diabetes. 2009 Nov;58(11):2649-55. doi: 10.2337/db09-0693. Epub 2009 Aug 3.

9.

The fibrosis marker galectin-3 and outcome in the general population.

de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P.

J Intern Med. 2012 Jul;272(1):55-64. doi: 10.1111/j.1365-2796.2011.02476.x. Epub 2011 Nov 18.

10.

Long-term intraindividual variability of serum lipids in patients with type I and type II diabetes.

Tsalamandris C, Panagiotopoulos S, Allen TJ, Waldrip L, Van Gaal B, Goodall I, Jerums G.

J Diabetes Complications. 1998 Jul-Aug;12(4):208-14.

PMID:
9647339
11.

Association between HbA1c variability and mortality in patients with type 2 diabetes.

Takao T, Matsuyama Y, Yanagisawa H, Kikuchi M, Kawazu S.

J Diabetes Complications. 2014 Jul-Aug;28(4):494-9. doi: 10.1016/j.jdiacomp.2014.02.006. Epub 2014 Feb 18.

PMID:
24703414
12.

Mortality in an elderly type 2 diabetic patients' cohort who attended a self-management educational workshop.

Perman G, Beratarrechea A, Aliperti V, Litwak L, Figar S, Alvarez A, Langlois E.

Prim Care Diabetes. 2011 Oct;5(3):175-84. doi: 10.1016/j.pcd.2011.03.002. Epub 2011 Apr 8.

PMID:
21482213
13.

Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes.

Lin CC, Li CI, Yang SY, Liu CS, Chen CC, Fuh MM, Chen W, Li TC.

Am J Med. 2012 Apr;125(4):416.e9-18. doi: 10.1016/j.amjmed.2011.07.027. Epub 2012 Feb 2.

PMID:
22305579
14.

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.

Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N.

Ann Intern Med. 2004 Sep 21;141(6):413-20.

PMID:
15381514
15.

Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study.

Zoppini G, Verlato G, Targher G, Bonora E, Trombetta M, Muggeo M.

Diabetes Metab Res Rev. 2008 Nov-Dec;24(8):624-8. doi: 10.1002/dmrr.897.

PMID:
18802932
16.

Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.

Okada T, Nakao T, Matsumoto H, Shino T, Nagaoka Y, Tomaru R, Wada T.

Intern Med. 2007;46(12):807-14. Epub 2007 Jun 15.

17.

Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes.

Wheeler SG, Ahroni JH, Boyko EJ.

Diabetes Res Clin Pract. 2002 Nov;58(2):131-8.

PMID:
12213355
18.

Atherosclerosis severity but not undiagnosed diabetes predicts new cardiovascular events of subjects in secondary cardiovascular prevention.

Rizza S, Copetti M, Cardellini M, Porzio O, Luzi A, Pecchioli C, Martelli E, Valentini A, Ippoliti A, Romeo F, Pellegrini F, Lauro D, Lauro R, Federici M.

Atherosclerosis. 2012 Aug;223(2):448-53. doi: 10.1016/j.atherosclerosis.2012.04.019. Epub 2012 May 24.

PMID:
22695529
19.

Pulse pressure and mortality from cerebrovascular diseases in type 2 diabetic patients: the Verona Diabetes Study.

Zoppini G, Verlato G, Zamboni C, Venturi C, Gennaro N, Biasi V, Bonora E, Muggeo M.

Cerebrovasc Dis. 2007;23(1):20-6. Epub 2006 Sep 12.

PMID:
16968982
20.

Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.

Xu L, Chan WM, Hui YF, Lam TH.

Diabet Med. 2012 Mar;29(3):393-8. doi: 10.1111/j.1464-5491.2011.03456.x.

PMID:
21916977

Supplemental Content

Support Center